Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K R Beutner

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
Obstetrics and Gynecology|October 1, 1990
Topical podofilox for the treatment of condylomata acuminata in womenD A Baker, J M Douglas, D M Buntin, et al.
International Journal of Dermatology|July 1, 1998
Butenafine, a fungicidal benzylamine derivative, used once daily for the treatment of interdigital tinea pedisB A Reyes, K R Beutner, S I Cullen, et al.
The Journal of Infectious Diseases|October 1, 1976
Distribution and characteristics of hepatitis B surface antigen in body fluids of institutionalized children and adultsM L Tiku, K R Beutner, R I Ramirez, et al.
Journal of the American Academy of Dermatology|March 5, 1998
Treatment of genital warts with an immune-response modifier (imiquimod)K R Beutner, S L Spruance, A J Hougham, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 24, 1999
Genital warts and their treatmentK R Beutner, D J Wiley, J M Douglas, et al.
Lancet (London, England)|April 15, 1989
Patient-applied podofilox for treatment of genital wartsK R Beutner, M A Conant, A E Friedman-Kien, et al.
Antimicrobial Agents and Chemotherapy|April 29, 1998
Imiquimod, a patient-applied immune-response modifier for treatment of external genital wartsK R Beutner, S K Tyring, K F Trofatter, et al.
The Pharmacogenomics Journal|April 26, 2017
Significant variation between SNP-based HLA imputations in diverse populations: the last mile is the hardestD J Pappas, A Lizee, V Paunic, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Obstetrics and Gynecology|October 1, 1990
Topical podofilox for the treatment of condylomata acuminata in womenD A Baker, J M Douglas, D M Buntin, et al.
International Journal of Dermatology|July 1, 1998
Butenafine, a fungicidal benzylamine derivative, used once daily for the treatment of interdigital tinea pedisB A Reyes, K R Beutner, S I Cullen, et al.
The Journal of Infectious Diseases|October 1, 1976
Distribution and characteristics of hepatitis B surface antigen in body fluids of institutionalized children and adultsM L Tiku, K R Beutner, R I Ramirez, et al.
Journal of the American Academy of Dermatology|March 5, 1998
Treatment of genital warts with an immune-response modifier (imiquimod)K R Beutner, S L Spruance, A J Hougham, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 24, 1999
Genital warts and their treatmentK R Beutner, D J Wiley, J M Douglas, et al.
Lancet (London, England)|April 15, 1989
Patient-applied podofilox for treatment of genital wartsK R Beutner, M A Conant, A E Friedman-Kien, et al.
Antimicrobial Agents and Chemotherapy|April 29, 1998
Imiquimod, a patient-applied immune-response modifier for treatment of external genital wartsK R Beutner, S K Tyring, K F Trofatter, et al.
The Pharmacogenomics Journal|April 26, 2017
Significant variation between SNP-based HLA imputations in diverse populations: the last mile is the hardestD J Pappas, A Lizee, V Paunic, et al.
Pageof 5